X0508 4 2024-05-21 0001439725 BIODESIX INC BDSX 0001021413 PATIENCE JOHN 919 WEST DILLON RD LOUISVILLE CO 80027 true true Chairman false Common Stock 2024-05-23 4 M 0 217400 A 4829611 I By John Patience Living Trust dated 7/23/1993 Common Stock 337926 D Common Stock 2078298 I By Patience Enterprises LP Common Stock 52988 I By Spouse Restricted Stock Units 2024-05-21 4 A 0 46686 0 A Common Stock 46686 46686 D Stock Options (Right to Buy) 1.57 2024-05-21 4 A 0 37050 0 A 2034-05-20 Common Stock 37050 37050 D Series A Non-Voting Convertible Preferred Stock 2024-05-23 4 M 0 5435 0 D Common Stock 217400 0 I By John Patience Living Trust dated 7/23/1993 The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993). The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock. These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. /s/ Robin H. Cowie as Attorney-in-Fact for John Patience 2024-05-23